[ Tue, Apr 25th 2017 ]: WOPRAI
[ Tue, Apr 25th 2017 ]: WOPRAI
Matthew Andrews Initiated (TGTX) at Strong Buy and Held Target at $23 on, Apr 25th, 2017
[ Tue, Apr 25th 2017 ]: WOPRAI
[ Mon, Apr 24th 2017 ]: WOPRAI
Vijay Kumar Upgraded (BDX) to Buy and Held Target at $200 on, Apr 24th, 2017
[ Mon, Apr 24th 2017 ]: WOPRAI
James Chappell Downgraded (BAC) to Hold and Held Target at $22 on, Apr 24th, 2017
[ Mon, Apr 24th 2017 ]: WOPRAI
[ Mon, Apr 24th 2017 ]: WOPRAI
Adam Jonas Initiated (VC) at Hold and Held Target at $103 on, Apr 24th, 2017
[ Mon, Apr 24th 2017 ]: WOPRAI
Heath Terry Maintained (AMZN) at Strong Buy with Increased Target to $55 on, Apr 24th, 2017
[ Mon, Apr 24th 2017 ]: WOPRAI
Helane Becker Upgraded (ALK) to Buy and Increased Target to $103 on, Apr 24th, 2017
[ Mon, Apr 24th 2017 ]: WOPRAI
Yuriy Vlasov Upgraded (ATI) to Hold and Held Target at $17 on, Apr 24th, 2017
[ Mon, Apr 24th 2017 ]: WOPRAI
[ Mon, Apr 24th 2017 ]: WOPRAI
Jacob Kilstein Upgraded (TRV) to Strong Buy and Held Target at $132 on, Apr 24th, 2017
[ Mon, Apr 24th 2017 ]: WOPRAI
[ Mon, Apr 24th 2017 ]: WOPRAI
Aldo Mazzaferro Upgraded (X) to Hold and Increased Target to $30 on, Apr 24th, 2017
[ Mon, Apr 24th 2017 ]: WOPRAI
Aldo Mazzaferro Upgraded (STLD) to Buy and Held Target at $44 on, Apr 24th, 2017
[ Mon, Apr 24th 2017 ]: WOPRAI
Will Slabaugh Upgraded (WING) to Buy and Held Target at $32 on, Apr 24th, 2017
[ Mon, Apr 24th 2017 ]: WOPRAI
Scott Stember Initiated (WGO) at Strong Buy and Held Target at $32 on, Apr 24th, 2017
[ Fri, Apr 21st 2017 ]: WOPRAI
SMMU, FRC, VOX, MBG, ASPS, SODA Are Seasonally Ripe To Go Up In the Next Five Weeks
[ Fri, Apr 21st 2017 ]: WOPRAI
CQP, ACOR, XPO, HALO, PSDV, HOLI Are Seasonally Ripe To Go Down In the Next Five Weeks
[ Fri, Apr 21st 2017 ]: WOPRAI
JO, NNA, TBNK, OMER, CVE, CDXS Are Seasonally Ripe To Go Down In the Next Five Weeks
[ Fri, Apr 21st 2017 ]: WOPRAI
TCRD, SANW, HGSH, BMA, VLO, BSBR Are Seasonally Ripe To Go Down In the Next Five Weeks
[ Fri, Apr 21st 2017 ]: WOPRAI
ACC, AKR, UIS, EFSC, CBU, WRB Expected To Be Down After Next Earnings Releases
[ Fri, Apr 21st 2017 ]: WOPRAI
[ Fri, Apr 21st 2017 ]: WOPRAI
JJSF, HTLF, CNI, BHLB, CDNS Expected To Be Up After Next Earnings Releases
[ Fri, Apr 21st 2017 ]: WOPRAI
GRC, WTBA, SVU, AVT, TGI, IPGP Expected To Be Up Before Next Earnings Releases
[ Fri, Apr 21st 2017 ]: WOPRAI
[ Fri, Apr 21st 2017 ]: WOPRAI
Patrick Brown Upgraded (CSX) to Buy and Held Target at $18 on, Apr 21st, 2017
[ Fri, Apr 21st 2017 ]: WOPRAI
Laura Chico Initiated (CDTX) at Strong Buy and Held Target at $280 on, Apr 21st, 2017
[ Fri, Apr 21st 2017 ]: WOPRAI
Andrew Strelzik Initiated (YUM) at Hold and Held Target at $66 on, Apr 21st, 2017
[ Fri, Apr 21st 2017 ]: WOPRAI
[ Fri, Apr 21st 2017 ]: WOPRAI
Jacquelynne Chimera Bohlen Upgraded (WABC) to Hold on, Apr 21st, 2017
[ Fri, Apr 21st 2017 ]: WOPRAI
Andrew Strelzik Initiated (WEN) at Buy and Held Target at $17 on, Apr 21st, 2017
[ Fri, Apr 21st 2017 ]: WOPRAI
[ Fri, Apr 21st 2017 ]: WOPRAI
Steven Chercover Upgraded (SON) to Hold and Increased Target to $54 on, Apr 21st, 2017
[ Fri, Apr 21st 2017 ]: WOPRAI
Aleksey Yefremov Downgraded (AXTA) to Hold on, Apr 21st, 2017
[ Fri, Apr 21st 2017 ]: WOPRAI
John Guinee Upgraded (BDN) to Strong Buy and Increased Target to $19 on, Apr 21st, 2017
[ Thu, Apr 20th 2017 ]: WOPRAI
CNET SqueezeTrigger Price is $1.32. There is $69,983 That Short Sellers Still Need To Cover.
[ Thu, Apr 20th 2017 ]: WOPRAI
CIDM SqueezeTrigger Price is $1.52. There is $843,948 That Short Sellers Still Need To Cover.
Array BioPharma Inc. (NASDAQ:ARRY), Up After BUYINS.NET Report Predicted Stock Would Go Up Due To Conditions Outlined In Our Re
April 21, 2017 / M2 PRESSWIRE / BUYINS.NET, www.buyins.net , a provider of unique trading technologies, released a report on Wednesday, April 19th 2017 at 17:47:00 PDT stating that Array BioPharma Inc. (NASDAQ) was expected to go Up due to the conditions presented in the following report. Click here to view the BUYINS.NET report:
http://www.buyins.net/releases/?id=526929
At the time this story was written, Array BioPharma Inc. (NASDAQ:ARRY) is Up By $0.42 (5.22%) since the BUYINS.NET report was released.
The movement of stock prices in the days and weeks leading to and following specific fundamental or technical events may follow a predictable pattern. Many companies stock price histories show random or unpredictable movements around certain events. But some seem to repeat the same pattern quarter after quarter, year after year. We use powerful computers to uncover those events and correlations to generate predictions with high probabilities of generating very specific returns within very specific time periods.
The specific technology used to make these predictions is available for a low monthly fee at: http://www.buyins.net/
About BUYINS.NET
BUYINS.NET, http://www.buyins.net, monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market-maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:
REGULATORY & COMPLIANCE NEWS Friction Factor - Market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements" Naked Shorts (RegSho) - Tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO
INVESTMENTS & TRADING Earnings - Predicts probability, price move and length of move before and after all US stock earnings reports Seasonality - Predicts probability, price move and length of move based on exact time of year for all US stocks Group Correlation - Tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups SqueezeTrigger - Massive database that tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock. Valuation - Tracks all known valuation models and applies them. GATS - Tracks and quantifies known trading strategies by backtesting, optimizing and running genetic algorithms and neural networks to ascertain best trading strategies. PatternScan - Automates tracking of every technical pattern and predicts next move in stocks. Insider - Tracks insiders trading records and determines trading performance. Trades by higher-level insiders are generally more predictive than trades by lower level insiders Events - Tracks patterns directly correlated to specific events.
SqueezeTrigger is a registered trademark, Reg. No. 3,120,641
DISCLAIMER:
BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. [symbol] has not approved the statements made in this release. Please read our report and visit our web site, http://www.buyins.net, for complete risks and disclosures.
Contact: BUYINS.NET Thomas Ronk 800-715-9999 tom@buyins.net http://www.buyins.net